Program
insulin degludec
Also written as “insulin degludec/insulin aspart”, “insulin degludec/liraglutide” and “Insulin degludec”.
Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus, led by 5 companies.
Drug pageInsulin degludec: every studyMany companies study it; this page follows only the 105 they lead. All 128 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novo Nordisk | 1000 open or running | phase 4since Sep 21, 2018 | Jan 30, 2008 | none ahead |
| Tonghua Dongbao Pharmaceuticalits history only | 22 open or running | phase 3since Aug 14, 2024 | Jun 2, 2024 | none ahead |
| Gan & Lee Pharmaceuticalsits history only | 11 open or running | phase 1since Aug 18, 2025 | Aug 18, 2025 | none ahead |
| Sino Biopharmaceuticalits history only | 11 open or running | phase 3since Jul 5, 2021 | Jul 5, 2021 | none ahead |
| Sunshine Lake Pharmaits history only | 10 open or running | phase 3since Mar 6, 2023 | Mar 6, 2023 | none ahead |
Also a collaborator on its studies: Profil Institut für Stoffwechselforschung.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Novo Nordisk only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 43 studies since Jan 6, 2011.
- Apr 8, 2015Phase 3 study in Diabetes MellitusNCT02420262 · 506 enrolled · United States, Argentina, Czechia and more
- Jul 15, 2015Phase 3 study in Diabetes MellitusNCT02501161 · 1,012 enrolled · United States, Argentina, Brazil and more
- Aug 28, 2015Phase 1 study in Diabetes MellitusNCT02536859 · 60 enrolled · Germany
- Nov 16, 2015Phase 3 study in Diabetes MellitusNCT02607306 · 819 enrolled · Japan
- Jan 5, 2016Phase 3 study in Diabetes MellitusNCT02648217 · 263 enrolled · Algeria, India, Lebanon and more
- May 3, 20162 phase 3 studies in Diabetes MellitusNCT02762578, NCT02773368
- Jul 22, 2016Phase 1 study in HealthyNCT02844790 · 24 enrolled · China
- Sep 15, 20162 phase 3 studies in Diabetes MellitusNCT02906917, NCT02911948
- Mar 10, 2017Phase 3 study in Diabetes MellitusNCT03078478 · 1,609 enrolled · United States, Canada, Denmark and more
- May 24, 20172 phase 3 studies in Diabetes MellitusNCT03175120, NCT03172494
- Sep 19, 2017Phase 1 study in Diabetes MellitusNCT03292185 · 24 enrolled · China
- Nov 16, 2017Phase 3 study in Diabetes MellitusNCT03377699 · 225 enrolled · Argentina, Australia, Austria and more
- Sep 21, 2018Phase 4 study in Diabetes Mellitus, Type 2NCT03687827 · 498 enrolled · United States, Canada, Poland and more
- Mar 10, 2021Phase 3 study in Diabetes Mellitus, Type 2NCT04795531 · 588 enrolled · United States, Argentina, Austria and more
TargetBeta
“Insulin receptor agonist”ChEMBL 37, by rule
Other programs on INSR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Insulin Glarginerule | Sanofi | phase 4 | 190 |
| Insulin Aspartrule | Novo Nordisk | phase 4 | 146 |
| Insulinrule | Pfizer | phase 4 | 50 |
| insulin glulisinerule | Sanofi | phase 4 | 43 |
| insulin icodecrule | Novo Nordisk | phase 4 | 30 |
| linsitinibrule | Astellas Pharma | phase 3 | 13 |
| LY3938577 | Eli Lilly | phase 2 | 3 |
Studies
The newest 60 of 100 Novo Nordisk leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT04795531Diabetes Mellitus, Type 2 · United States, Argentina, Austria and more | 3 | Completed | Jun 23, 2022 | 588 |
| NCT03687827Diabetes Mellitus, Type 2 · United States, Canada, Poland and more | 4 | Completed | Dec 20, 2019 | 498 |
| NCT03377699Diabetes Mellitus · Argentina, Australia, Austria and more | 3 | Completed | Dec 17, 2020 | 225 |
| NCT03292185Diabetes Mellitus · China | 1 | Completed | Jan 2, 2018 | 24 |
| NCT03175120Diabetes Mellitus · China, Hong Kong | 3 | Completed | Mar 5, 2019 | 453 |
| NCT03172494Diabetes Mellitus · China | 3 | Completed | Jun 14, 2019 | 720 |
| NCT03078478Diabetes Mellitus · United States, Canada, Denmark and more | 3 | Completed | Feb 13, 2019 | 1,609 |
| NCT02911948Diabetes Mellitus · Japan | 3 | Completed | Nov 17, 2017 | 210 |
| NCT02906917Diabetes Mellitus · United States, Algeria, Czechia and more | 3 | Completed | Aug 31, 2017 | 532 |
| NCT02844790Healthy · China | 1 | Completed | Sep 26, 2016 | 24 |
| NCT02773368Diabetes Mellitus · United States, Argentina, Canada and more | 3 | Completed | Sep 26, 2017 | 420 |
| NCT02762578Diabetes Mellitus · China | 3 | Completed | May 19, 2017 | 543 |
| NCT02648217Diabetes Mellitus · Algeria, India, Lebanon and more | 3 | Completed | Sep 4, 2016 | 263 |
| NCT02607306Diabetes Mellitus · Japan | 3 | Completed | Dec 15, 2017 | 819 |
| NCT02536859Diabetes Mellitus · Germany | 1 | Completed | Apr 14, 2016 | 60 |
| NCT02501161Diabetes Mellitus · United States, Argentina, Brazil and more | 3 | Completed | Oct 3, 2018 | 1,012 |
| NCT02420262Diabetes Mellitus · United States, Argentina, Czechia and more | 3 | Completed | Oct 5, 2016 | 506 |
| NCT02298192Diabetes Mellitus · United States, Austria, Bulgaria and more | 3 | Completed | Dec 23, 2015 | 420 |
| NCT02100475Diabetes Mellitus · United States, Argentina, Australia and more | 3 | Completed | Apr 2015 | 31 |
| NCT02034513Diabetes Mellitus · United States, Poland, Puerto Rico | 3 | Completed | Jan 11, 2016 | 501 |
| NCT02030600Diabetes Mellitus · United States, Puerto Rico | 3 | Completed | Dec 4, 2015 | 721 |
| NCT01959529Diabetes Mellitus · United States, Algeria, Argentina and more | 3 | Completed | Oct 16, 2016 | 7,637 |
| NCT01952145Diabetes Mellitus · United States, Argentina, Australia and more | 3 | Completed | Nov 4, 2014 | 557 |
| NCT01916174Diabetes Mellitus · Germany | 1 | Completed | Nov 2013 | 50 |
| NCT01880736Diabetes Mellitus · Japan | 3 | Completed | Apr 2014 | 458 |
| NCT01868581Diabetes Mellitus · Germany | 1 | Completed | Aug 2008 | 58 |
| NCT01868568Diabetes Mellitus · Germany | 1 | Completed | Aug 2008 | 55 |
| NCT01868555Diabetes Mellitus · Japan | 1 | Completed | Feb 2008 | 32 |
| NCT01868529Diabetes Mellitus · Germany | 1 | Completed | Jun 2008 | 63 |
| NCT01865331Diabetes Mellitus · Germany | 1 | Completed | Mar 2007 | 32 |
| NCT01865318Diabetes Mellitus · Germany | 1 | Completed | Jan 2007 | 36 |
| NCT01865305Diabetes Mellitus · Germany | 1 | Completed | Feb 2007 | 59 |
| NCT01865292Diabetes Mellitus · Germany | 1 | Completed | Nov 2006 | 40 |
| NCT01849289Diabetes Mellitus · United States, Brazil, Canada and more | 3 | Completed | May 15, 2014 | 833 |
| NCT01835431Diabetes Mellitus · United States, Belgium, Brazil and more | 3 | Completed | Nov 7, 2014 | 362 |
| NCT01814137Diabetes Mellitus · United States, Algeria, Germany and more | 3 | Completed | Mar 2014 | 40 |
| NCT01773798Diabetes Mellitus · Austria | 1 | Completed | Aug 2013 | 33 |
| NCT01713530Diabetes Mellitus · United States, Algeria, Austria and more | 3 | Completed | Jan 9, 2014 | 274 |
| NCT01704417Diabetes Mellitus · Germany | 1 | Completed | Mar 2013 | 40 |
| NCT01680341Diabetes Mellitus · United States, Algeria, Germany and more | 3 | Completed | Aug 22, 2013 | 272 |
| NCT01676116Diabetes Mellitus · United States, Australia, France and more | 3 | Completed | Mar 11, 2014 | 438 |
| NCT01664247Diabetes Mellitus · United States, Canada, France and more | 3 | Completed | Dec 31, 2013 | 346 |
| NCT01618162Diabetes Mellitus · United States, Bulgaria, Canada and more | 3 | Completed | Oct 23, 2013 | 435 |
| NCT01623375Diabetes Mellitus · Germany | 1 | Completed | Aug 2012 | 18 |
| NCT01590836Diabetes Mellitus · Germany | 1 | Completed | Jun 2012 | 22 |
| NCT01570751Diabetes Mellitus · United States, Puerto Rico | 3 | Completed | Jan 2014 | 145 |
| NCT01569841Diabetes Mellitus · United States | 3 | Completed | Nov 2012 | 24 |
| NCT01513590Diabetes Mellitus · Algeria, Bulgaria, Croatia and more | 3 | Completed | Nov 19, 2012 | 394 |
| NCT01513473Diabetes Mellitus · United States, Bulgaria, Finland and more | 3 | Completed | Jul 30, 2013 | 350 |
| NCT01467414Diabetes Mellitus · Germany | 1 | Terminated | Dec 2011 | 1 |
| NCT01455142Diabetes Mellitus · Austria | 1 | Completed | Jan 2012 | 32 |
| NCT01437592Diabetes Mellitus · China | 1 | Completed | Nov 22, 2011 | 24 |
| NCT01392573Diabetes Mellitus · United States, Bulgaria, Denmark and more | 3 | Completed | Oct 1, 2012 | 413 |
| NCT01388361Diabetes Mellitus · United States, Austria, Belgium and more | 3 | Completed | Jul 2012 | 413 |
| NCT01365507Diabetes Mellitus · United States, Korea, Republic of, Malaysia and more | 3 | Completed | Apr 2012 | 276 |
| NCT01364428Diabetes Mellitus · United States | 3 | Completed | Jan 2012 | 373 |
| NCT01336023Diabetes Mellitus · United States, Australia, Canada and more | 3 | Completed | May 24, 2012 | 1,663 |
| NCT01326026Diabetes Mellitus · United States, Finland, Germany and more | 3 | Completed | Dec 2011 | 222 |
| NCT01319240Diabetes Mellitus · Germany | 1 | Completed | May 2011 | 24 |
| NCT01272193Diabetes Mellitus · Japan | 3 | Completed | Sep 2011 | 296 |
How it is read
Names in the registry
- “insulin degludec”, 73 entries
- “insulin degludec/insulin aspart”, 35 entries
- “insulin degludec/liraglutide”, 17 entries
- “Insulin degludec”, 4 entries
- “Insulin degludec/liraglutide”, 3 entries
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 58 studies
- Diabetes Mellitus, Type 1, 31 studies
- Diabetes Mellitus, 16 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.